ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Bioventus Inc

Bioventus Inc (BVS)

9,78
0,05
(0,51%)
Fermé 28 Juin 10:00PM
9,78
0,03
(0,31%)
Après les heures de négociation: 1:00AM

Bioventus Inc (BVS) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
9,78
( 0,51% )
Prix Achat
9,60
Prix Vente
10,06
Volume échangé
1 435 059
9,4171 Fourchette du Jour 9,88
5,81 Plage de 52 semaines 11,2493
Cap du marché
Clôture Veille
9,73
Ouverture
9,64
Dernière Transaction
1
@
9.6206
Dernière heure de transaction
Volume financier
US$ 13 977 254
VWAP
9,7398
Volume moyen (3 m)
US$ 566 884
Actions en circulation
67 748 048
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
21,81
Bénéfice par action (BPA)
0,4
Chiffre d'affairess (LTM)
576,3M
Bénéfice net (LTM)
28,48M

À propos de Bioventus Inc

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve sti... Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a benchtop device that processes whole blood to produce high-yield PRP with a 10-minute single-spin cycle. It also offers precision bone resection for patients with degenerative spine conditions and spinal deformities, as well as enables precision ultrasonic neuro and general surgery to address brain tumors and pathologies of the liver and other organs; and bone graft substitutes, including various products that facilitate optimal bone fusion. In addition, the company provides neXus, an ultrasonic surgical system; BoneScalpel, a surgical solution enabling precise cuts in hard tissue; BoneScalpel Access, for bone removal with visualization; SonaStar system, a precise ablation and removal of soft tissue; SonaStar Elite handpiece and accessories; SonicOne, an ultrasonic cleansing and debridement system; Osteoamp, an allograft-derived bone graft for orthopedic, neurosurgical, and reconstructive bone grafting procedures; Signafuse bone graft; Purebone, a natural osteoconductive scaffold; and Reficio demineralized bone matrix. The company’s restorative therapies include minimally invasive fracture treatments and rehabilitation products. Its products also include Exogen, an ultrasound bone stimulation system. The company sells its products to healthcare institutions, physicians, patients, distributors and dealers. Bioventus Inc. was founded in 2011 and is headquartered in Durham, North Carolina. Show more

Secteur
Healthcare
Industrie
Medical Equipment & Supplies
Siège social
Durham, United States
Fondé
2026
Bioventus Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker BVS. Le dernier cours de clôture d'Bioventus était de US$9,73. Au cours de la dernière année, les actions de Bioventus ont été négociées dans une fourchette de prix de US$ 5,81 à US$ 11,2493.

Bioventus compte actuellement 67 748 048 actions en circulation. La capitalisation boursière d'Bioventus est de US$662,58 million. Bioventus a un ratio cours/bénéfice (ratio PE) de 21.81.

BVS Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
11.0812.41379310348.79.788.635646239.33468383CS
40.9210.38374717838.869.787.816693458.72363642CS
120.778.546059933419.0111.24937.815816289.46938956CS
262.2329.53642384117.5511.24937.144464959.07467959CS
523.0946.18834080726.6911.24935.814118438.12804756CS
1566.89238.4083044982.8914.382.713645057.76280334CS
260-9.19-48.444913020618.9719.94090.79994024516.59160354CS

BVS - Frequently Asked Questions (FAQ)

What is the current Bioventus Inc share price?
The current share price of Bioventus Inc is US$ 9,78
How many Bioventus Inc shares are in issue?
Bioventus Inc has 67 748 048 shares in issue
What is the market cap of Bioventus Inc?
The market capitalisation of Bioventus Inc is USD 662,58M
What is the 1 year trading range for Bioventus Inc share price?
Bioventus Inc has traded in the range of US$ 5,81 to US$ 11,2493 during the past year
What is the PE ratio of Bioventus Inc?
The price to earnings ratio of Bioventus Inc is 21,81
What is the cash to sales ratio of Bioventus Inc?
The cash to sales ratio of Bioventus Inc is 1,03
What is the registered address of Bioventus Inc?
The registered address for Bioventus Inc is 4721 Emperor Boulevard, Durham, North Carolina, 27703
What is the Bioventus Inc website address?
The website address for Bioventus Inc is www.bioventus.com
Which industry sector does Bioventus Inc operate in?
Bioventus Inc operates in the Medical Equipment & Supplies sector

BVS Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock